Literature DB >> 29693060

Helicobacter cinaedi bacteremia mimicking eosinophilic fasciitis in a patient with X-linked agammaglobulinemia.

Ashley Hill1, Adam Byrne2, Danielle Bouffard3, Me Linh Luong4, Melissa Saber1, Hugo Chapdelaine5.   

Abstract

Entities:  

Keywords:  Eosinophilic fasciitis; Helicobacter cinaedi; X-linked agammaglobulinemia; XLA, X-linked agammaglobulinemia

Year:  2018        PMID: 29693060      PMCID: PMC5911815          DOI: 10.1016/j.jdcr.2017.11.016

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN: 2352-5126


× No keyword cloud information.

Introduction

Bruton agammaglobulinemia (XLA) is an X-linked genetic disorder characterized by severe antibody deficiency. The cornerstone of treatment is immunoglobulin replacement therapy, but patients remain at risk for recurrent sinopulmonary, gastrointestinal, and skin infections. XLA has also been associated several inflammatory and autoimmune diseases such as arthritis, inflammatory bowel disease, and, more recently, eosinophilic fasciitis. Helicobacter cinaedi is reportedly involved in several cutaneous manifestations ranging from cellulitis3, 4 to superficial ulcers on erythematous, eroded plaques. We report a case of H cinaedi bacteremia mimicking eosinophilic fasciitis in a patient with XLA.

Case report

An 18-year-old man with X-linked agammaglobulinemia supplemented with monthly intravenous immunoglobulins presented with a 1-year history of abrupt-onset, progressive erythematous plaques, first on his left ankle then on his right posterior calf. The plaques were painful, especially with prolonged standing or exercise. He complained of feeling feverish without objectified temperature and had a sense of general fatigue and malaise. He denied taking any new medications. On physical examination, the patient presented with 2 erythematous, ill-defined, warm, and markedly indurated plaques in an asymmetric distribution reaching 11 × 10 cm on the left ankle and right posterior calf. Neither a groove sign, visible as a linear depression along the course of superficial veins in the upper limbs, as seen in eosinophilic fasciitis, nor a lilac border suggestive of morphea, were appreciable (Fig 1, A). Signs of systemic sclerosis such as Raynaud, sclerodactyly, or nailfold capillary changes were absent. Differential diagnosis included morphea profunda, eosinophilic fasciitis, systemic scleroderma, infectious panniculitis, lupus panniculitis, and erythema induratum. Inflammatory markers were strikingly elevated but peripheral eosinophilia and increased muscular markers were absent. A deep elliptical biopsy was performed on the right posterior calf. Pathology findings showed an abnormally fibrotic dermis and hypodermis with neovascularization of the dermis, fascia, and skeletal muscle (Fig 2, A). A polymorphous infiltrate, rich in eosinophils, was present within the dermis, hypodermis, fascia, and skeletal muscle (Fig 2, B). Results of periodic acid–Schiff–diastase and Warthin-Starry tissue stain were negative as was tissue culture for bacteria, mycobacteria, and deep mycoses. Magnetic resonance imaging found fascial enhancement and thickening of the right posterior calf. In light of these findings, a diagnosis of eosinophilic fasciitis was proposed, and standard treatment with monthly pulses of methylprednisolone combined with high doses of oral prednisone was initiated. Methotrexate was introduced as a steroid-sparing agent, and steroid tapering was attempted. However, the patient had a recurrence of symptoms and deterioration of inflammatory markers every time steroid tapering was attempted. The recurrent nature of the illness led to the suspicion of a possible underlying infectious process; thus, blood cultures were obtained. Blood cultures came back positive with a curved gram-negative bacillus; however, all subculture media remained negative after 5 days of incubation. As such, 16S rRNA gene polymerase chain reaction and sequencing was performed directly on the blood culture broth, and the microorganism was identified as H cinaedi. The patient was started on intravenous meropenem, 1 g every 8 hours, and oral doxycycline, 100 mg twice daily for a total of 6 weeks, as cephalosporins and penicillins show moderate to high minimum inhibitory concentrations,6, 7 and resistance has been described. After just 2 weeks of treatment, his inflammatory markers returned to normal, and he showed substantial improvement clinically in terms of erythema, induration, and functionality (Fig 1, B).
Fig 1

A, Two erythematous, indurated plaques on the right posterior calf and left medial ankle at presentation. B, Left ankle posttreatment.

Fig 2

A, Fibrosis and neovascularization of the dermis, fascia, and skeletal muscle B, Infiltrate rich in eosinophils in the dermis. (Hematoxylin phloxine saffron stain; original magnifications: A, ×10; B, ×40.)

A, Two erythematous, indurated plaques on the right posterior calf and left medial ankle at presentation. B, Left ankle posttreatment. A, Fibrosis and neovascularization of the dermis, fascia, and skeletal muscle B, Infiltrate rich in eosinophils in the dermis. (Hematoxylin phloxine saffron stain; original magnifications: A, ×10; B, ×40.)

Discussion

H cinaedi has been increasingly reported as the cause of recurrent fever and bacteremia and a variety of cutaneous manifestations in patients with XLA. Most cases have been described as recurrent mild cellulitis, but superficial ulcerations resembling pyoderma gangrenosum, erythema, hyperpigmented macules, and an “erysipelaslike eruption” have been described.9, 10 Given the association of autoimmune manifestations in these patients and the difficulty in culturing this organism, H cinaedi infections are often misdiagnosed. As such, H cinaedi infection should be considered in immunocompromised patients presenting with atypical skin lesions, as prompt diagnosis and treatment with antimicrobials agents can lead to significant clinical improvement.
  10 in total

1.  Recurrent superficial cellulitis-like erythema associated with Helicobacter cinaedi bacteremia.

Authors:  Yuko Adachi; Chie Moriya; Tomomi Fujisawa; En Shu; Hiroyuki Kanoh; Asami Nakayama; Jun Yonetamari; Mariko Seishima
Journal:  J Dermatol       Date:  2016-01-30       Impact factor: 4.005

Review 2.  Clinical and bacteriological characteristics of Helicobacter cinaedi infection.

Authors:  Yoshiaki Kawamura; Junko Tomida; Yuji Morita; Shigemoto Fujii; Tatsuya Okamoto; Takaaki Akaike
Journal:  J Infect Chemother       Date:  2014-07-09       Impact factor: 2.211

3.  Autoimmunity and inflammation in X-linked agammaglobulinemia.

Authors:  Vivian P Hernandez-Trujillo; Chris Scalchunes; Charlotte Cunningham-Rundles; Hans D Ochs; Francisco A Bonilla; Ken Paris; Leman Yel; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2014-06-10       Impact factor: 8.317

4.  Helicobacter cinaedi - an emerging form of cellulitis.

Authors:  Z Laftah; R Hay
Journal:  Br J Dermatol       Date:  2016-07       Impact factor: 9.302

5.  Recurrent Cellulitis Caused by Helicobacter cinaedi in a Patient with X-linked Agammaglobulinaemia.

Authors:  Masayo Sugimoto; Takuya Takeichi; Hideki Muramatsu; Daiei Kojima; Yukari Osada; Michihiro Kono; Seiji Kojima; Masashi Akiyama
Journal:  Acta Derm Venereol       Date:  2017-02-08       Impact factor: 4.437

6.  Pyoderma gangrenosum-like ulcer caused by Helicobacter cinaedi in a patient with x-linked agammaglobulinaemia.

Authors:  J Dua; E Elliot; P Bright; S Grigoriadou; R Bull; M Millar; N Wijesuriya; H J Longhurst
Journal:  Clin Exp Dermatol       Date:  2012-03-22       Impact factor: 3.470

7.  Shulman disease (eosinophilic fasciitis) in X-linked agammaglobulinemia.

Authors:  A Pituch-Noworolska; H Mach-Tomalska; A Szaflarska; D Adamek
Journal:  Pol J Pathol       Date:  2016-06       Impact factor: 1.072

Review 8.  Cutaneous manifestations of Helicobacter cinaedi: a review.

Authors:  S Shimizu; H Shimizu
Journal:  Br J Dermatol       Date:  2016-02-18       Impact factor: 9.302

9.  Helicobacter cinaedi bacteremia resulting from antimicrobial resistance acquired during treatment for X-linked agammaglobulinemia.

Authors:  Meiwa Toyofuku; Junko Tomida; Yoshiaki Kawamura; Ippei Miyata; Yuki Yuza; Yuho Horikoshi
Journal:  J Infect Chemother       Date:  2016-03-31       Impact factor: 2.211

10.  Refractory to treat Helicobacter cinaedi bacteremia with bilateral lower extremities cellulitis in an immunocompetent patient.

Authors:  Yuichi Shimizu; Harumi Gomi; Haruhiko Ishioka; Momoko Isono
Journal:  IDCases       Date:  2016-06-06
  10 in total
  1 in total

Review 1.  Infections With Enterohepatic Non-H. pylori Helicobacter Species in X-Linked Agammaglobulinemia: Clinical Cases and Review of the Literature.

Authors:  Carolina Romo-Gonzalez; Juan Carlos Bustamante-Ogando; Marco Antonio Yamazaki-Nakashimada; Francisco Aviles-Jimenez; Francisco Otero-Mendoza; Francisco Javier Espinosa-Rosales; Sara Elva Espinosa-Padilla; Selma Cecilia Scheffler Mendoza; Carola Durán-McKinster; Maria Teresa García-Romero; Marimar Saez-de-Ocariz; Gabriela Lopez-Herrera
Journal:  Front Cell Infect Microbiol       Date:  2022-02-04       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.